Industries > Pharma > 3D Printing for Healthcare World Market 2018-2028

3D Printing for Healthcare World Market 2018-2028

Forecasts by Products (Dental Products, Medical Implants, Bio-Printing, Others), by Technology (Hardware, Software, Services) & Analysis of Opportunities in Personalised Medicine, Medical Devices, Tailor Made Prosthetics, Orthopaedic Implants & Drugs

PUBLISHED: 26 April 2018
PAGES: 192
PRODUCT CODE: PHA0306

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0306 Categories: , Tag:

The 3D Printing for Healthcare market is expected to grow at a CAGR of 19.6% in the first half of the forecast period. In 2017, the dental products segment held the largest share in the 3D Printing for Healthcare market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 192-page report you will receive 67 tablets and 102 figures– all unavailable elsewhere.

The 192-page report provides clear detailed insight into the 3D Printing for Healthcare market Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• 3D Printing Healthcare market forecasts from 2018-2028

• This report also breaks down the revenue forecast for the 3D Printing Healthcare market by products:
• Dental Products
• Medical Implants
• Bio-Printing
• Others

Each submarket is further broken down by region: North America, South America, Europe, Asia-Pacific, RoW

• This report also breaks down the revenue forecast for the 3D Printing Healthcare market by technology:
• Hardware
• Software
• Services

Each submarket is further broken down by region: North America, South America, Europe, Asia-Pacific, RoW

• This report also breaks down the revenue forecast for the 3D Printing Healthcare market by regional and national market:
• North America: US, Canada, Mexico
• South America: Brazil, Argentina, Paraguay, Bolivia, Rest of South America
• Europe: Germany, France, UK, Spain, Italy, Rest of Europe
• Asia-Pacific: China, Japan, India, Australia, Thailand, Rest of Asia-Pacific
• RoW: Middle East, Africa, Other Countries

3D Printing for Healthcare World Market 2018-2028

• Our study gives qualitative analysis of the 3D Printing Healthcare market. It discusses the Drivers and Restraints that influence this market as well as the Porter’s Five Forces Analysis, SWOT Analysis and STEP Analysis of the 3D Printing Healthcare market.

• Our study discusses the selected leading companies that are the major players in the 3D Printing Healthcare industry:
• 3D Systems Inc.
• Arcam AB
• Autodesk Inc.
• ExOne Company
• H Intressenter AB
• Optomec, Inc.
• Organovo Holdings, Inc.
• Ponoko Limited
• Stratasys Ltd
• Voxeljet AG

Visiongain’s study is intended for anyone requiring commercial analyses for the 3D Printing Healthcare market. You find data, trends and predictions.

Buy our report today 3D Printing for Healthcare World Market 2018-2028:
Forecasts by Products (Dental Products, Medical Implants, Bio-Printing, Others), by Technology (Hardware, Software, Services) & Analysis of Opportunities in Personalised Medicine, Medical Devices, Tailor Made Prosthetics, Orthopaedic Implants & Drugs
.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for 3D Printing for Healthcare World Market 2018-2028


Download sample pages

Complete the form below to download your free sample pages for 3D Printing for Healthcare World Market 2018-2028


Latest Pharma news

“Global Influenza Vaccines Market Set to Grow to $4.9bn by 2024” says new Visiongain report

The global vaccines market is one that is driven by innovation. This is vital for maintaining the rich pipeline of vaccines seen in the human vaccines market.

05 July 2019

READ

“Pharmaceutical Wholesale & Distribution Organizations 2019 is estimated to reach $1.4bn in 2024” says Visiongain report

Opportunities in the market stem from the increasing use of specialist and generic drugs, which have higher profit margins; global expansion into the emerging markets; vertical integration of wholesalers; and the increasing use of pharmaceuticals.

28 June 2019

READ

“Global Vaccines Sales market set to grow to $75bn by 2024” says new Visiongain report

Progress in R&D in the therapeutic vaccine field will yield revolutionary results and answer unmet medical needs. This will also lead to more innovative approaches to vaccine development.

25 June 2019

READ

“Global Inflammatory Bowel Diseases (IBD) Drug Market is estimated to reach $8.6bn by 2024” says new Visiongain report

Revenue growth will be driven by rising incidence and prevalence owing to modern lifestyles and improved awareness and diagnosis.

21 June 2019

READ

Categories

Category